The global tissue diagnostics market size reached US$ 5.5 Billion in 2023. Looking forward, the market is projected to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.14% during 2023-2032.
Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.
Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.
2. What is the expected growth rate of the global tissue diagnostics market during 2024-2032?
3. What are the key factors driving the global tissue diagnostics market?
4. What has been the impact of COVID-19 on the global tissue diagnostics market?
5. What is the breakup of the global tissue diagnostics market based on the product type?
6. What is the breakup of the global tissue diagnostics market based on the technology?
7. What is the breakup of the global tissue diagnostics market based on the disease?
8. What is the breakup of the global tissue diagnostics market based on the end-user?
9. What are the key regions in the global tissue diagnostics market?
10. Who are the key players/companies in the global tissue diagnostics market?
Tissue diagnostics include the analysis and testing of specific tissue samples by capturing the biological context of diseases. They are used to detect certain medical conditions like cancer and inflammatory disorders and reveal the exact type and degree of malignancy which assists in identifying potential causes and treatment options. Tissue diagnostics are highly accurate, inexpensive and can be carried out by different techniques like core and open biopsy. Nowadays, advanced technologies like immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology and special staining are also being employed for performing these diagnoses.
Owing to the declining fertility rates and increased life expectancy, the overall share of the geriatric population is currently experiencing steady growth worldwide. This is a crucial factor contributing to the market growth as older adults are more susceptible to chronic diseases and thus require frequent check-ups and diagnoses. Apart from this, altering food patterns, rising alcohol consumption and reduced physical activities among individuals have led to a rise in the incidences of several lifestyle diseases. In addition to this, the rising prevalence of various types of cancers among all age groups has also led to a surge in demand for these diagnostic services.
Key Market Segmentation
This report provides an analysis of the key trends in each sub-segment of the global tissue diagnostics market report, along with forecasts at the global and regional level from 2024-2032. The report has categorized the market based on product type, technology, disease and end-user.Breakup by Product Type:
- Instruments
- Consumables
Breakup by Technology:
- Immunohistochemistry
- In Situ Hybridization
- Digital Pathology and Workflow Management
- Special Staining
Breakup by Disease:
- Breast Cancer
- Gastric Cancer
- Lymphoma
- Prostate Cancer
- Non-Small Cell Lung Cancer
- Others
Breakup by End-User:
- Hospitals
- Research Laboratories
- Pharmaceutical Companies
- Contract Research Organizations
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape
The report has also analysed the competitive landscape of the market with some of the key players being Roche, Danaher, Thermo Fisher Scientific, Abbott, Agilent Technologies, Merck, Sakura Finetek Japan, Abcam, BD, Qiagen, Bio SB, Biogenex, Cell Signaling Technology, etcKey Questions Answered in This Report
1. How big is the global tissue diagnostics market?2. What is the expected growth rate of the global tissue diagnostics market during 2024-2032?
3. What are the key factors driving the global tissue diagnostics market?
4. What has been the impact of COVID-19 on the global tissue diagnostics market?
5. What is the breakup of the global tissue diagnostics market based on the product type?
6. What is the breakup of the global tissue diagnostics market based on the technology?
7. What is the breakup of the global tissue diagnostics market based on the disease?
8. What is the breakup of the global tissue diagnostics market based on the end-user?
9. What are the key regions in the global tissue diagnostics market?
10. Who are the key players/companies in the global tissue diagnostics market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Tissue Diagnostics Market
6 Market Breakup by Product Type
7 Market Breakup by Technology
8 Market Breakup by Disease
9 Market Breakup by End-User
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
14 Price Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Roche
- Danaher
- Thermo Fisher Scientific
- Abbott
- Agilent Technologies
- Merck
- Sakura Finetek Japan
- Abcam
- BD
- Qiagen
- Bio SB
- Biogenex
- Cell Signaling Technology
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | April 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 5.5 Billion |
| Forecasted Market Value ( USD | $ 9.4 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
